Preface: innovative therapeutics.
Ted
T
Rosen
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D065095:Calcineurin Inhibitors; D003879:Dermatologic Agents / Q000627:therapeutic use; D006801:Humans; D000069283:Rituximab; D012871:Skin Diseases / Q000188:drug therapy*; D035703:Therapies, Investigational; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D065095:Calcineurin Inhibitors; D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha; D000069283:Rituximab